-
Journal of HIV Therapy
- Publisher:
- Mediscript Ltd.
- Publication date:
- 2009-05-27
- ISBN:
- 1462-0308
- Copyright:
- COPYRIGHT TV Trade Media, Inc.<br/>COPYRIGHT GALE, Cengage Learning. All rights reserved.
Latest documents
- SILCAAT and ESPRIT: taking stock.
- Implications of the SILCAAT and ESPRIT trials and the future for HIV immunotherapy.
- A review of the use of activation markers in Africa.
- HIV immunology: what lessons can we learn from recent vaccine trials?
- Lymphocyte activation in HIV-1 infection: time for quality control.
- Immune activation and the pathogenesis of HIV disease: implications for therapy.
- Inflammation and gut permeability.
- HIV as an inflammatory disease.
- HIV, atherosclerosis and inflammation: implications for treatment.
- Forthcoming events.
Featured documents
- A review of the use of activation markers in Africa.
- Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications?
- Nucleoside analogues in 2008.
- Integrase inhibitors: a clinical review of raltegravir and elvitegravir.
- HIV, atherosclerosis and inflammation: implications for treatment.
- 48TH annual ICAAC/IDSA 46th annual meeting, Washington DC, 25-28 October 2008.
- Immune activation and viraemia: reciprocal interactions in disease pathogenesis.
- Gastrointestinal imaging in HIV.
- Resistance testing methodologies and mechanisms of resistance.
- Magnetic resonance imaging and spectroscopy of the brain in HIV disease.